How Sociodemographics, Presence of Oncology Specialists, and Hospital Cancer Programs Affect Accrual to Cancer Treatment Trials
Michaele C. Christian(Walter Reed Army Institute of Research), Richard S. Ungerleider(Unknown), Malcolm A. Smith(National Cancer Institute), Leslie G. Ford, Richard Kaplan(University College London), Edward L. Trimble(Memorial Sloan Kettering Cancer Center), Nancy Breen(Waters (United States)), Otis W. Brawley(Johns Hopkins University), Mary S. McCabe(Memorial Sloan Kettering Cancer Center), Jeffrey S. Abrams(National Cancer Institute)
Cited by 531
Related Papers
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|914
Approaching Health Disparities From a Population Perspective: The National Institutes of Health Centers for Population Health and Health Disparities
|American Journal of Public Health|2008|565
American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care
|Journal of Clinical Oncology|2013|473
Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients
|JNCI Journal of the National Cancer Institute|2006|415